PsychedelicNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) CYB003 Phase 1/2a Clinical Trial Through Clinilabs Begins Enrollment
Jul 12, 2022
Clinilabs Drug Development Corporation, a global, full-service contract research organization with deep expertise in central nervous system drug development, today announced commencement of enrollment in a phase 1/2a clinical trial of CYB003. Being developed by Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” CYB003 is the first novel psilocybin analog to be evaluated in phase 1/2a development for the treatment of major depressive disorder (“MDD”). “Clinilabs is honored to be working with Cybin, an innovator in the development of novel psychedelic therapeutics, to conduct its first-in-human clinical trial of CYB003,” said Clinilabs Vice President of Strategy and Corporate Development Jeanine Falinski. “We are excited by the potential of these therapeutics and hope that the future is life-changing for individuals suffering from mental illness. We are encouraged by the interest from potential research participants who have already come forward prior to today.”
To view the full press release, visit https://ibn.fm/WSX69
About Cybin Inc.
Cybin is a leading ethical biopharmaceutical company working with a network of world-class partners and internationally recognized scientists on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. The company is focused on progressing Psychedelics to Therapeutics(TM) by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders. For more information, visit the company’s website at www.Cybin.com.
NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]
PsychedelicNewsWire is part of the InvestorBrandNetwork.
More News
Faisal Islam: The two big decisions the chancellor must make
He must consider the longevity of Iran war economic pressures and how to sustain modest optimism, writes the BBC's Faisal Islam.
As A.I. Makes Law Firms More Efficient, Clients Ask: ‘Where’s My Discount?’
There’s growing pressure to move beyond the billable hour. But big firms aren’t ready to blow up their trusted business model.
Heathrow Airport warns third runway could be delayed by four years
The UK's busiest airport cautions it may miss the government target of 2035 as ministers say the deadline has "always been ambitious".
White House Blocks CNN From Covering Trump’s Trip to Tennessee
CNN won’t be able to join President Trump on a Saturday trip to Tennessee. He had banned CNN and two other news outlets from the White House, but a court order on Thursday restored their access.
This Screw Is Needed for Missiles and Planes. Buying One Can Take Years.
As the Trump administration scrambles to increase the production of munitions, these special screws are expensive and hard to source.
China-US relationship is critical for the world
The China-US relationship is critical for the world, and dialogue and cooperation between the two countries are essential for global stability and predictability: This is the overwhelming view on this week's Chinese and US leaders' meetings in Washington, D.C., with ties improving, and AI and trade most watched.
China and US can contribute to addressing global challenges
The Chinese and US Presidents met at the White House on September 24 and exchanged views on the future of bilateral relations. The meeting drew global attention, with international figures weighing in on its significance.
Could an iced coffee freeze you out of the job market?
Employees and recruiters weigh into the online debate around interview etiquette.
US venture builder: Deeper China-US AI cooperation benefits all
China and the US could deepen cooperation to make AI benefit all, said Steve Hoffman, a prominent Silicon Valley venture capitalist and chairman & CEO of Founders Space, in an interview with CMG.
A 7-Day Standoff That Said So Much About Trump and the Media
An abrupt decree, a network boycott, a legal intervention and an uneasy détente: This was no typical battle between a president and his press corps.
High Gas and Rising Mortgage Rates Trouble Trump as Midterms Near
As the president extolled the strength of the economy on the global stage, Americans continued to feel the sting of rising prices stemming from the war in Iran.
Scottish drivers hit as diesel passes £2 a litre across the country
Motoring organisation the RAC says it expects the average UK diesel price to hit a new record high over the weekend.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.